An Umbrella Trial Based on Molecular Pathway for Patients With Metastatic TNBC.
Status:
Recruiting
Trial end date:
2023-11-15
Target enrollment:
Participant gender:
Summary
This is a Phase II, open-label, randomized controlled umbrella trial evaluating the efficacy
and safety of multiple targeted treatment in patients with metastaticTNBC.